Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
Online Ketamine Treatment Available in: AZ, CA, CO, FL, GA, NY, OR, TX, and WA.
Ketamine therapy has emerged as one of the most significant developments in mental health treatment in recent decades. Originally developed as an anesthetic in the 1960s, ketamine is now being used off-label by physicians to help patients with treatment-resistant depression, anxiety, PTSD, and other conditions that have not responded to conventional medications. This comprehensive guide covers everything you need to know, from how ketamine works in the brain to what a treatment session feels like, costs, safety considerations, and how to choose the right provider.
Ketamine therapy refers to the medically supervised use of ketamine, typically at sub-anesthetic doses, to treat mental health conditions such as depression, anxiety, PTSD, and OCD. Unlike traditional psychiatric medications that may take weeks to show effects, ketamine has been observed to produce rapid improvements in mood and psychological well-being in some patients, often within hours to days of the first session.
Ketamine was first synthesized in 1962 and received FDA approval as an anesthetic in 1970. Its potential as a mental health treatment was discovered serendipitously when researchers observed antidepressant effects in patients receiving ketamine for surgical procedures. Since a landmark study published in 2000 demonstrated rapid antidepressant effects from a single intravenous dose, research into ketamine for psychiatric use has expanded dramatically. For a deeper dive into this history, see our article on the history of ketamine for mental health treatment.
Today, ketamine therapy is offered in several formats: intravenous (IV) infusions in specialized clinics, intranasal sprays (including the FDA-approved esketamine product Spravato), and oral or sublingual tablets taken at home under telehealth supervision. Each approach has different considerations in terms of cost, convenience, and clinical evidence, which we explore in detail below.
Ketamine works through a fundamentally different mechanism than traditional antidepressants like SSRIs and SNRIs. While conventional medications primarily target serotonin and norepinephrine systems, ketamine acts on the glutamate system, the brain's most abundant excitatory neurotransmitter. This distinction is a key reason why ketamine may help patients who have not responded to other treatments.
At its core, ketamine blocks NMDA (N-methyl-D-aspartate) receptors, which triggers a cascade of downstream effects. This NMDA receptor blockade leads to increased glutamate release and subsequent activation of AMPA receptors, initiating molecular signaling pathways that promote synaptic growth and repair. For a detailed explanation, read our article on ketamine's rapid antidepressant mechanism through NMDA and glutamate.
One of the most compelling aspects of ketamine's antidepressant action is its ability to promote neuroplasticity, the brain's capacity to form new neural connections and reorganize existing ones. Research suggests that ketamine increases levels of brain-derived neurotrophic factor (BDNF), a protein essential for the growth, survival, and differentiation of neurons. This may help reverse the synaptic damage and neural atrophy observed in chronic depression. Our in-depth post on ketamine, BDNF, and neuroplasticity explores this mechanism further.
Additional research has examined how long ketamine-induced neuroplasticity lasts and how it compares to neuroplasticity effects from other psychedelics like psilocybin.
Emerging evidence also suggests that ketamine may have anti-inflammatory properties that could contribute to its antidepressant effects, as neuroinflammation has been increasingly linked to depression. Additionally, research has begun exploring the gut-brain axis and ketamine's interaction with the microbiome, opening new avenues for understanding its therapeutic effects.
Ketamine therapy is most commonly explored for patients who have not found adequate relief through conventional treatments. It is important to note that, aside from esketamine (Spravato) for treatment-resistant depression, ketamine is used off-label for the following conditions:
Depression is the most extensively studied indication for ketamine therapy. Patients with treatment-resistant depression, typically defined as depression that has not responded to two or more adequate antidepressant trials, may benefit significantly. Studies have shown rapid reductions in depressive symptoms, sometimes within hours. Learn more in our dedicated guide on ketamine for depression and our overview of ketamine therapy for depression.
Research suggests ketamine may help reduce symptoms of various anxiety disorders, including generalized anxiety disorder and social anxiety disorder. For more on the evidence, see our articles on how ketamine works for anxiety and ketamine therapy for anxiety.
Clinical trials have demonstrated that ketamine may rapidly reduce PTSD symptoms, including intrusive thoughts and hyperarousal. Research on ketamine's role in fear memory reconsolidation suggests it may help the brain process traumatic memories differently. Visit our PTSD conditions page and clinical evidence review for more detail.
Preliminary studies suggest ketamine may provide rapid but temporary relief from obsessive-compulsive symptoms. While more research is needed, the findings are encouraging for patients who have not responded to SSRIs or cognitive behavioral therapy. Read more on our OCD conditions page and our post on emerging evidence for ketamine and OCD.
Research is also exploring ketamine for bipolar depression, postpartum depression, suicidal ideation (where rapid-acting interventions are especially valuable), chronic pain with comorbid depression, and alcohol use disorder.
Take the first step by scheduling a consultation with one of our board-certified physicians.
Book a ConsultationKetamine is available in several different formulations, each with its own advantages, clinical considerations, and cost profiles. Understanding the differences can help you have a more productive conversation with your provider.
Oral ketamine, often in the form of troches (lozenges) or tablets, is placed under the tongue (sublingual) for absorption. This is the form most commonly used in at-home ketamine therapy programs. It offers the convenience of home-based treatment with telehealth physician oversight. Bioavailability is lower than IV administration, so doses are adjusted accordingly. Real-world outcomes from sublingual ketamine programs have been promising.
Intravenous infusions are administered in a clinical setting and provide the most precise dosing and highest bioavailability. A typical session lasts 40 to 60 minutes, with patients monitored throughout. IV infusions are the most extensively studied route of administration in clinical research. For a detailed comparison, see our guide on oral ketamine vs. IV infusion.
Intranasal ketamine can be compounded by pharmacies or administered as Spravato (esketamine), the only ketamine-derived product FDA-approved for treatment-resistant depression. Spravato must be administered in a certified healthcare setting with monitoring. Learn about the differences in our article on Spravato vs. generic ketamine.
Ketamine exists as two mirror-image molecules (enantiomers): S-ketamine (esketamine) and R-ketamine. Most ketamine therapy uses the racemic mixture (50/50 blend). Emerging research on R-ketamine suggests it may have antidepressant effects with fewer dissociative side effects. For a detailed breakdown, read our post on racemic ketamine vs. R-ketamine vs. S-ketamine and our comparison of esketamine vs. racemic ketamine.
Preparation is an important part of maximizing the potential benefits of ketamine therapy. We recommend reading our detailed guide on the 9 things you should do before your ketamine sessions. Key preparation steps include fasting for a few hours before treatment, arranging a calm and comfortable environment, setting intentions, and ensuring you have a support person available if treating at home.
During a ketamine session, patients typically experience altered perception, mild dissociation, and changes in sensory awareness. Many describe the experience as dreamlike. Sessions generally last one to two hours depending on the route of administration. Some patients find that music enhances their experience, and Isha Health provides a healing music playlist for use during sessions.
Post-session integration is widely considered a critical component of ketamine therapy. Learn about what to expect after taking oral ketamine. Many providers recommend journaling after sessions to process insights and emotions that may arise. Psychedelic integration therapy can help patients incorporate their experiences into lasting change.
The cost of ketamine therapy varies significantly depending on the route of administration, provider, and location. For a thorough breakdown, read our article on how much ketamine therapy costs and visit our pricing page.
Most ketamine therapy (other than Spravato) is not directly covered by insurance, as it is considered off-label use. However, many providers offer superbills that patients can submit for potential out-of-network reimbursement. Learn more about ketamine therapy insurance and superbills. HSA and FSA funds can typically be used toward ketamine treatment costs.
Ketamine has a well-characterized safety profile from decades of use in anesthesia. At the lower therapeutic doses used for mental health treatment, side effects are generally mild and transient. For comprehensive safety information, see our safety information page and our article on ketamine's long-term safety profile.
Common side effects during or shortly after treatment include:
A common concern is whether ketamine is addictive. At the low, medically supervised doses used in therapeutic settings, the risk of dependence appears to be low based on current research. Our article on whether ketamine therapy is addictive and our post on ketamine's addictive potential relative to other medications explore this topic in detail.
It is important to note that ketamine therapy is not appropriate for everyone. Contraindications may include uncontrolled hypertension, active substance use disorders, certain psychotic disorders, and pregnancy. A thorough medical evaluation by a qualified provider is essential before beginning treatment. Check whether you may be a candidate on our Am I a Candidate? page.
Choosing the right ketamine therapy provider is one of the most important decisions in your treatment journey. The quality of medical oversight, integration support, and ongoing care can significantly influence outcomes. We have written a dedicated guide on how to choose a ketamine therapy provider that covers this topic comprehensively.
Key factors to consider include:
To learn about how Isha Health approaches treatment, visit our treatment approach page. You can also use our ketamine therapist directory to find a qualified therapist who can support your integration process.
Isha Health provides physician-led, at-home ketamine therapy with personalized treatment plans and ongoing support.
Schedule Your ConsultationKetamine itself is FDA-approved as an anesthetic, not specifically for depression. It is prescribed off-label by licensed physicians for depression and other mental health conditions. Esketamine (Spravato), a derivative of ketamine, is FDA-approved for treatment-resistant depression and major depressive disorder with suicidal ideation.
Some patients report noticeable improvements in mood within hours to days after their first session, which is significantly faster than traditional antidepressants that typically require four to six weeks. However, individual responses vary, and a full course of treatment is generally recommended.
When administered under medical supervision at appropriate therapeutic doses, ketamine therapy has a well-established safety profile. Common side effects include temporary dissociation, nausea, dizziness, and mild increases in blood pressure. Read our long-term safety article for more details.
Costs vary by route and provider. IV infusions typically range from $400 to $800 per session. At-home oral ketamine through Isha Health starts at approximately $350 per appointment plus $50 to $150 per month for medication. See our pricing page for current rates.
Yes. Oral or sublingual ketamine can be prescribed by a licensed physician and taken at home under a structured telehealth program. Isha Health provides at-home ketamine therapy with ongoing physician oversight, medication delivery, and integration support.
At the low, medically supervised doses used in therapeutic settings, the risk of dependence appears to be low based on current evidence. However, ketamine does have abuse potential at higher doses. Working with a qualified provider who monitors your treatment is essential. Learn more in our article on ketamine and addiction risk.
Medical disclaimer: This guide is for informational purposes only and does not constitute medical advice. Ketamine is FDA-approved as an anesthetic; its use for depression, anxiety, PTSD, and other psychiatric conditions is off-label. Always consult with a qualified healthcare provider before starting any new treatment. Last updated: April 2026.
